DELENEX THERAPEUTICS

delenex-therapeutics-logo

Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company's fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically validated technology delivers antibodies exhibiting the highest affinity, solubility and stability all combined with a very low risk of immunogenicity.

#SimilarOrganizations #People #Financial #Website #More

DELENEX THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2009-01-01

Address:
Zรผrich, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.delenex.com

Total Employee:
1+

Status:
Active

Contact:
41 44 730 51 80

Total Funding:
41.3 M USD

Technology used in webpage:
SPF Amazon Amazon Frankfurt Region


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

levoss-logo

LevOss

LevOss is developing a biodegradable material (polymer) embedded with a Nano mesh.

panoptes-pharma-logo

Panoptes Pharma

Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.

resistentia-pharmaceuticals-logo

Resistentia Pharmaceuticals

Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

thomas-dyrberg_image

Thomas Dyrberg Board of Directors @ Delenex Therapeutics
Board_member

Current Employees Featured

arnd-kaltofen_image

Arnd Kaltofen
Arnd Kaltofen Director @ Delenex Therapeutics
Director
2009-01-01

thomas-hecht_image

Thomas Hecht
Thomas Hecht Executive Chairman @ Delenex Therapeutics
Executive Chairman

Founder


dominik-escher_image

Dominik Escher

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Venture Round - Delenex Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Delenex Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Delenex Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics

vi-partners_image

VI Partners

VI Partners investment in Series A - Delenex Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Delenex Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Delenex Therapeutics

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series A - Delenex Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Delenex Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics

Official Site Inspections

http://www.delenex.com

  • Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
  • IP address: 13.56.33.8
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Delenex Therapeutics" on Search Engine